QCG
MIRM icon

Quadrant Capital Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Quadrant Capital Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.86K Hold
31
– – ﹤0.01% 2458
2025
Q4 		$2.45K Hold
31
– – ﹤0.01% 2483
2025
Q3 		$2.27K Buy
+31
New +$1.97K ﹤0.01% 2451
2025
Q2 		– Sell
-117
Closed -$5.27K – 2096
2025
Q1 		$5.27K Hold
117
– – ﹤0.01% 2343
2024
Q4 		$4.84K Buy
+117
New +$4.88K ﹤0.01% 2308

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Quadrant Capital Group's MIRM Position: Q1 2026 in Review

Quadrant Capital Group held its Mirum Pharmaceuticals (MIRM) position steady in Q1 2026 at 31 shares worth $2.86K. The position accounts for ﹤0.01% of the portfolio, ranked #2458.

Quadrant Capital Group first reported a position in MIRM in Q4 2024 and has held it in 5 quarters since. The position peaked at $5.27K in Q1 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Quadrant Capital Group held 31 shares of Mirum Pharmaceuticals worth $2.86K as of Q1 2026.
  • Quadrant Capital Group left its Mirum Pharmaceuticals share count unchanged in Q1 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2458 holding.
  • Quadrant Capital Group first reported a position in Mirum Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • Quadrant Capital Group's Mirum Pharmaceuticals position peaked at $5.27K in Q1 2025.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.